Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer

William H. West, Kurt W. Tauer, John R. Yannelli, +4

New England Journal of Medicine

Cancer ImmunosurveillancePartial ResponsesMedicineMalignant Blood DisorderImmunology +12

Natural Cytotoxic Reactivity of Human Lymphocytes Against a Myeloid Cell Line: Characterization of Effector Cells

William H. West, Grace B. Cannon, H. David Kay, +2

The Journal of Immunology

ImmunotoxicologyImmunologyBlood CellComplement ReceptorImmunotherapy +15

A Functional Comparison of Human Fc-Receptor-Bearing Lymphocytes Active in Natural Cytotoxicity and Antibody-Dependent Cellular Cytotoxicity

H. David Kay, Guy D. Bonnard, William H. West, +1

The Journal of Immunology

ImmunotoxicologyLaboratory ImmunologyLymphocyte DevelopmentImmunologyImmune Regulation +20

Targeting the p300/CBP Axis in Lethal Prostate Cancer

Jonathan Welti, Adam Sharp, Nigel Brooks, +33

Cancer Discovery

Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial

Robert O. Dillman, Neil M. Barth, Robert K. Oldham, +8

Cancer

Fc Receptors on Mouse Effector Cells Mediating Natural Cytotoxicity Against Tumor Cells

Ronald B. Herberman, Scott Bartram, J. S. Haskill, +3

The Journal of Immunology

ImmunotoxicologyImmunologyCell DeathImmunophenotypingImmunotherapy +17

Peripheral Blood Stem Cell Mobilization by Chemotherapy With and Without Recombinant Human Granulocyte Colony-Stimulating Factor

LEE S. SCHWARTZBERG, Robert Birch, B Hazelton, +9

Journal of Hematotherapy

Human T Lymphocyte Subpopulations: Correlation Between E-Rosette-Forming Affinity and Expression of the Fc Receptor

William H. West, Susan Payne, James L. Weese, +1

The Journal of Immunology

ImmunohematologyT-regulatory CellImmunologyImmune RegulationBlood Cell +17

Rosette Formation by the Human K Cell

William H. West, R. Bryan Boozer, Ronald B. Herberman

The Journal of Immunology

Clinical ImmunologyImmunohematologyLaboratory ImmunologyLymphocyte DevelopmentImmunology +19

Randomized Trial of Filgrastim, Sargramostim, or Sequential Sargramostim and Filgrastim After Myelosuppressive Chemotherapy for the Harvesting of Peripheral-Blood Stem Cells

Charles H. Weaver, Kevin A. Schulman, Barbara Wilson-Relyea, +3

Journal of Clinical Oncology